Previous close | 57.09 |
Open | 57.58 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 620.00 |
Expiry date | 2026-01-16 |
Day's range | 57.09 - 57.58 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Intuitive Surgical's third-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.
Strength in Analytical Instrument and Specialty Diagnostics segments is likely to have driven Thermo Fisher's third-quarter 2024 performance.
Myriad Genetics and Ultima Genomics to explore the latter's sequencing platform for advanced clinical tests in oncology and reproductive genomics.